| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |